Table 2.
Pretransplant HBV serologic results and HBV-related events after transplantation n (%)
| 
Pretransplantation HBV serologic result | 
HBV-related events after transplantation | 
|||||
| HBsAg | Anti-HBs | Anti-HBc | Anti-HBe | Patients | HBV reactivation/total patients | Loss of antibody/total patients | 
| Negative | Negative | Negative | Negative | 45 (50.0) | 1/45 | 1/45 | 
| Negative | Positive | Negative | Negative | 15 (16.7) | - | 8/15 | 
| Negative | Negative | Positive | Negative | 3 (3.3) | 2/3 | 1/3 | 
| Negative | Negative | Negative | Positive | 1 (1.1) | - | - | 
| Positive | Negative | Negative | Negative | 3 (3.3) | - | - | 
| Positive | Negative | Positive | Positive | 3 (3.3) | - | - | 
| Negative | Negative | Positive | Positive | 5 (5.6) | - | - | 
| Negative | Positive | Negative | Positive | 3 (3.3) | - | - | 
| Negative | Positive | Positive | Negative | 6 (6.7) | - | 4/6 | 
| Negative | Positive | Positive | Positive | 6 (6.7) | - | - | 
HBV: Hepatitis B virus (HBV); HBsAg: HBV surface antigen; anti-HBs: Antibody to HBV surface antigen; anti-HBc: Antibody to HBV core antigen.